Intravital microscopy reveals endothelial dysfunction in resistance arterioles in Angiotensin II-induced hypertension

Hypertension Research

Volumn 35, Issue 8, 2012, Pages 855-861

  Schäfer, Stephan C ^a   Pellegrin, Maxime ^b   Wyss, Caroline ^b   Aubert, Jean François ^b   Nussberger, Jürg ^b   Hayoz, Daniel ^c   Lehr, Hans Anton ^b   Mazzolai, Lucia ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Hpital Cantonal ^*  (Switzerland)

Author keywords

angiotensin II; conductance vessels; endothelial dependent vasorelaxation; resistance arterioles

Indexed keywords

ANGIOTENSIN II;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA WALL; ARTERIOLE; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; EX VIVO STUDY; INTRAVITAL MICROSCOPY; MALE; MICROSCOPY; MOUSE; NONHUMAN; RENOVASCULAR HYPERTENSION; THORACIC AORTA; VASODILATATION; WILD TYPE;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIES; ARTERIOLES; BIOMECHANICS; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; HEART RATE; HYPERTENSION, RENOVASCULAR; MICE; NITRIC OXIDE DONORS; RENIN; S-NITROSO-N-ACETYLPENICILLAMINE; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 84864646423     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.58     Document Type: Article

References (50)

1. Landmesser U, Drexler H. Endothelial function and hypertension. Curr Opin Cardiol 2007; 22: 316-320.
2. Higashi Y, Oshima T, Ozono R, Matsuura H, Kajiyama G. Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension 1997; 30: 252-258.
3. Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes Jr DR, Lerman A. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 2000; 35: 1654-1660.
4. Ward NC, Croft KD, Hodgson J, Rich L, Beilin LJ, Puddey IB. Brachial artery vasomotor function is inversely associated with 24-h ambulatory blood pressure. J Hypertens 2004; 22: 967-972.
5. Sainsbury CA, Coleman J, Brady AJ, Connell JM, Hillier C, Petrie Jr. Endothelium-dependent relaxation is resistant to inhibition of nitric oxide synthesis, but sensitive to blockade of calcium-Avtivated potassium channels in essential hypertension. J Hum Hypertens 2007; 21: 808-814.
6. Bauersachs J, Bouloumié A, Mülsch A, Wiemer G, Fleming I. Busse. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc Res 1998; 37: 772-779.
7. Sunano S, Watanabe H, Tanaka S, Sekiguchi F, Shimamura K. Endothelium-derived relaxing, contracting and hyperpolarizing factors of mesenteric arteries of hypertensive and normotensive rats. Br J Pharmacol 1999; 126: 709-716.
8. Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 2000; 101: 1722-1728.
9. Sekiguchi F, Yamamoto K, Matsuda K, Kawata K, Negishi M, Shinomiya K, Shimamur K, Sunano S. Endothelium-dependent relaxation in pulmonary arteries of L-NAME-treated Wistar and stroke-prone spontaneously hypertensive rats. J Smooth Muscle Res 2002; 38: 131-144.
10. Touyz RM, Deschepper C, Park JB, He G, Chen X, Neves MF, Virdis A, Schiffrin EL. Inhibition of mitogen-Activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats. J Hypertens 2002; 20: 1053-1054.
11. De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol 2005; 516: 253-259.
12. Lima VV, Giachini FR, Choi H, Carneiro FS, Carneiro ZN, Fortes ZB, Carvalho MH, Webb RC, Tostes RC. Impaired vasodilator activity in deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GicNAcylation. Hypertension 2009; 53: 166-174.
13. Mazzolai L, Duchosal MA, Korber M, Bouzourene K, Aubert JF, Hao H, Vallet V, Brunner HR, Nussberger J, Gabbiani G, Hayoz D. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/-mice. Hypertension 2004; 44: 277-282.
14. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-Angiotensin system and cardiovascular risk. Lancet 2007; 369: 1208-1219.
15. Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophy-siology. Clin Sci (Lond) 2007; 112: 417-428.
16. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendlin KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916-1923.
17. Nakane H, Miller Jr FJ, Faraci FM, Toyoda K, Heistad DD. Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction. Hypertension 2000; 35: 595-601.
18. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 2004; 22: 535-542.
19. Wölkart G, Stessel H, Brunner F. In vivo administration of D-Arginine: effects on blood pressure and vascular function in angiotensin II-induced hypertensive rats. Atherosclerosis 2004; 176: 219-225.
20. Sarr M, Chataigneau M, Martins S, Schott C, El Bedoui J, Oak MH, Muller B, Chataigneau T, Schini-Kerth VB. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res 2006; 71: 794-802.
21. Stec DE, Vera T, McLemore Jr GR, Kelsen S, Rimoldi JM, Gadepalli RS, Ryan MJ. Heme oxygenase-1 induction does not improve vascular relaxation in angiotensin II hypertensive mice. Am J Hypertens 2008; 21: 189-193.
22. Brouwers-Ceiler DL, Nelissen-Vrancken HJ, Smits JF, De Mey JG. The influence of angiotensin II-induced increase in aortic wall mass on compliance in rats in vivo. Cardiovasc Res 1997; 33: 478-484.
23. Fitch RM, Rutledge JC, Wang YX, Powers AF, Tseng JL, Clary T, Rubanyi GM. Synergistic effect of angiotensin II and nitric oxide synthase inhibitor in increasing aortic stiffness in mice. Am J Physiol Heart Circ Physiol 2006; 290: H1190-H1198.
24. Mahmud A, Feely J. Effect of angiotensin ii receptor blockade on arterial stiffness: beyond blood pressure reduction. Am J Hypertens 2002; 15: 1092-1095.
25. Okura T, Watanabe S, Kurata M, Koresawa M, Irita J, Enomoto D, Jotoku M, Miyoshi K, Fukuoka T, Higaki J. Long-term effects og angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension. Clin Exp Hypertens 2008; 30: 415-422.
26. Simon P, Levenson J. Use of arterial compliance for evaluation of hypertension. Am J Hypert 1991; 4: 97-105.
27. Hayoz D, Rutschmann B, Perret F, Niederberger M, Tardy Y, Mooser V, Nussberger J, Waeber B, Brunner HR. Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension 1992; 20: 1-6.
28. Laurent S, Hayoz D, Trazzi S, Boutouyrie P, Waeber B, Omboni S, Brunner HR, Mancia G, Safar M. Isobaric compliance of the radial artery is increased in patients with essential hypertension. J Hypertens 1993; 11: 89-93.
29. Longo D, Zaetta V, Perkovic D, Frezza P, Ragazzo F, Mos L, Santonastaso M, Garbelotto R, Benetos A, Palatini P. Impaired arterial elasticity in young patients with yhite-coat hypertension. Blood Press Monit 2006; 11: 243-249.
30. Stewart AD, Jiang B, Millasseau SC, Ritter JM, Chowienczyk PJ. Acute reduction of blood pressure by nitroglycerin does not normalize large artery stiffness in essenetial hypertension. Hypertension 2006; 48: 404-410.
31. Erdogan D, Caliskan M, Yildirim I, Gullu H, Baycan S, Ciftci O, Yildirir A, Muderrisoglu H. Effects of normal blood pressure, prehypertension and hypertension on left ventricular diastolic function and aortic elastic properties. Blood Press 2007; 16: 114-121.
32. Kotchen TA, Kotchen JM, Grim CE, Krishnaswami S, Kidambi S. Aldosterone and alterations of hypertension-related vascular function in African Americans. Am J Hypertens 2009; 22: 319-324.
33. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 1997; 29: 1025-1030.
34. Nussberger J, Aubert JF, Bouzourene K, Pellegrin M, Hayoz D, Mazzolai L. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesar-tan, atenolol, and amlodipine. Hypertension 2008; 51: 1306-1311.
35. Lehr HA, Leunig M, Menger MD, Nolte D, Messmer K. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol 1993; 143: 1055-1062.
36. Schäfer SC, Wallerath T, Closs EI, Schmidt C, Schwarz PM, Förstermann U, Lehr HA. Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles. Am J Physiol Heart Circ Physiol 2005; 288: H436-H444.
37. de Wit C, Esser N, Lehr HA, Bolz SS, Pohl U. Pentobarbital-sensitive EDHF comediates ACh-induced arteriolar dilation in the hamster microcirculation. Am J Physiol 1999; 276: H1527-H1534.
38. allerath T, Witte K, Schäfer SC, Schwarz PM, Prellwitz W, Wohlfart P, Kleinert H, Lehr HA, Lemmer B, Förstermann U. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA 1999; 96: 13357-13362.
39. Brunner J, Krummenauer F, Lehr HA. Quantification of video-taped images in microcirculation research using inexpensive imaging software (Adobe Photoshop). Microcirculation 2000; 7: 103-107.
40. Pellegrin M, Alonso F, Aubert JF, Bouzourene K, Braunersreuther V, Mach F, Haefliger JA, Hayoz D, Berthelot A, Nussberger J, Laurant P, Mazzolai L. Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changes. Hypertension 2009; 53: 782-789.
41. Tardy Y, Hayoz D, Mignot JP, Richard P, Brunner HR, Meister JJ. Dynamic non-invasive measurements of arterial diameter and wall thickness. J Hypertens 1992; 10: S105-S109.
42. Hayoz D, Tardy Y, Rutschmann B, Mignot JP, Achakri H, Feihl F, Meister JJ, Waeber B, Brunner HR. Spontaneous diameter oscillations of the radial artery in humans. Am J Physiol 1993; 264: H2080-H2084.
43. Zanchi A, Stergiopulos N, Brunner HR, Hayoz D. Differences in the mechanical properties of the rat carotid artery in vivo, in situ, and in vitro. Hypertension 1998; 32: 180-185.
44. Li R, Wang WQ, Zhang H, Yang X, Fan Q, Christopher TA, Lopez BL, Tao L, Goldstein BJ, Gao F, Ma XL. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. Am J Physiol Endocrinol Metab 2007; 293: E1703-E1708.
45. Arruda RMP, Peotta VA, Meyrelles SS, Vasquez EC. Evaluation of vascular function in apolipoprotein E knockout mice with Ang-dependent renovascular hypertension. Hypertension 2005; 46: 932-936.
46. Peng X, Haldar S, Deshpande S, Irani K, Kass DA. Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium. Hypertension 2003; 41: 378-381.
47. Nakano T, Tominaga R, Nagano I, Okabe H, Yasui H. Pulsatile flow enhances endothelium-derived nitric oxide release in the peripheral vasculature. Am J Physiol Heart Circ Physiol 2000; 278: H1098-H1104.
48. Silacci P, Desgeorges A, Mazzolai L, Chambaz C, Hayoz D. Flow pulsatility is a critical determinant of oxidative stress in endothelial cells. Hypertension 2001; 38: 1162-1166.
49. Holowatz LA, Thompson-Torgerson CS, Kenney WL. The human cutaneous circulation as a model of generalized microvascular dysfunction. J Appl Physiol 2008; 105: 370-372.
50. Heo HJ, Yun MR, Jung KH, Lee JY, Park JY, Lee SJ, Bae SS, Lee WS, Kim CD. Endogenous angiotensin II enhances atherogenesis in apolipoprotein E-deficient mice with renovascular hypertension through activation of smooth muscle cells. Life Sci 2007; 80: 1057-1063.